Study on the No.253 Lymph Node Metastasis Patterns in Left-Sided Colon and Rectal Cancer

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorCancer Institute and Hospital, Chinese Academy of Medical Sciences

About this trial

The goal of this observational study is to learn about the the pattern of metastasis of the No.253 lymph node in colorectal cancer. The main questions it aims to answer are: 1. What are the risk factors for metastasis to the No.253 lymph node? 2.What is the prognosis for patients with metastasis to the No.253 lymph node? Patients with descending colon cancer, sigmoid colon cancer, and rectal cancer who undergo curative surgery with dissection of the No.253 lymph node are included in this study

Eligibility criteria

Qualifiers

Age: 18-75 years;

Underwent laparoscopic left hemicolectomy, sigmoid colectomy, or rectal cancer radical surgery.

Postoperative pathology confirmed as adenocarcinoma.

No evidence of distant metastasis.

Disqualifiers

Previous history of malignant colorectal tumors.

Patients who have undergone multiple abdominal-pelvic surgeries.

Patients undergoing emergency surgery due to complications such as intestinal obstruction, intestinal perforation, or intestinal bleeding.

Surgery did not achieve R0 resection.

Trial design

Treatments tested in this trial

  • Laparoscopic colorectal surgery

Treatment groups

3,000 Participants
are divided into 1 treatment group

Sponsors and collaborators

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Lead sponsor

Peking Union Medical College Hospital

Collaborator

Peking University Cancer Hospital & Institute

Collaborator

China-Japan Friendship Hospital

Collaborator

Chinese PLA General Hospital

Collaborator